glp-1 super responder Everyone wants to be a to the GLP1s, most people are not. Super responders are more sensitive to GLP1 medications often at lower doses and lose more weight than average Some people lose far more

Instead, it provides greater choice, allowing treatment to be tailored to individual preferences, lifestyles and healthcare needs

Unlike traditional weight-loss medications that target only one metabolic pathway, Tirzepatide activates two key hormone receptors (GIP & GLP-1)

The official prescribing information does not assign nausea or constipation a universal 24-to-72-hour onset window

Durell N et al

We work with members on Ozempic, Wegovy, Mounjaro, and Zepbound regularly

A change that keeps returning, or one linked to high glucose readings, deserves more attention than a one-off change after certain foods or temporary dehydration